Hydnocarpin as a Potent Xanthine Oxidase Inhibitor from Hydnocarpus anthelmintica: Affinity-Guided Identification and Kinetic Characterization

Background/Objectives: Xanthine oxidase (XO) is a therapeutic target for hyperuricemia. Although hydnocarpin inhibits XO, its comparative potency and kinetic characteristics remain insufficiently characterized. This study investigated XO-inhibitory constituents of Hydnocarpus anthelmintica through affinity-guided dereplication. Methods: Extracts and fractions were screened for XO inhibition. Affinity ultrafiltration and chromatographic profiling guided compound identification. Three flavonoids were identified using authentic standards, whereas hydnocarpin was isolated and characterized. Inhibitory activities, enzyme kinetics, and molecular docking were evaluated, with allopurinol serving as a positive control in the inhibition assay. Results: The EtOAc fraction exhibited potent XO inhibition (IC50 = 2.7 ± 0.3 µg/mL). Among the four compounds evaluated, hydnocarpin (4) showed the strongest inhibitory activity (IC50 = 0.10 ± 0.01 µM), followed by luteolin (1, 0.41 ± 0.04 µM), chrysoeriol (3, 0.62 ± 0.03 µM), and apigenin (2, 0.76 ± 0.07 µM). Allopurinol, used as the positive control, exhibited an IC50 of 4.2 ± 0.4 µM. Kinetic analysis indicated mixed-type inhibition, with KI and KIS values of 0.079 and 0.158 µM, respectively. Molecular docking suggested differences in predicted interactions between two hypothetical stereochemical models, although the absolute configuration of the isolated compound was not determined. Conclusions: Affinity-guided dereplication identified potent XO-inhibitory constituents of H. anthelmintica, highlighting hydnocarpin as the strongest inhibitor among those tested and supporting further mechanistic investigation.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-19
DOI
https://doi.org/10.3390/ph19111845
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hydnocarpin as a Potent Xanthine Oxidase Inhibitor from Hydnocarpus anthelmintica: Affinity-Guided Identification and Kinetic Characterization

Heung Joo Yuk, Dong-Seon Kim
Pharmaceuticals
Gout, Hyperuricemia, Uric Acid
article

Hydnocarpin as a Potent Xanthine Oxidase Inhibitor from Hydnocarpus anthelmintica: Affinity-Guided Identification and Kinetic Characterization

Heung Joo Yuk, Dong-Seon Kim
article en

Abstract

Background/Objectives: Xanthine oxidase (XO) is a therapeutic target for hyperuricemia. Although hydnocarpin inhibits XO, its comparative potency and kinetic characteristics remain insufficiently characterized. This study investigated XO-inhibitory constituents of Hydnocarpus anthelmintica through affinity-guided dereplication. Methods: Extracts and fractions were screened for XO inhibition. Affinity ultrafiltration and chromatographic profiling guided compound identification. Three flavonoids were identified using authentic standards, whereas hydnocarpin was isolated and characterized. Inhibitory activities, enzyme kinetics, and molecular docking were evaluated, with allopurinol serving as a positive control in the inhibition assay. Results: The EtOAc fraction exhibited potent XO inhibition (IC50 = 2.7 ± 0.3 µg/mL). Among the four compounds evaluated, hydnocarpin (4) showed the strongest inhibitory activity (IC50 = 0.10 ± 0.01 µM), followed by luteolin (1, 0.41 ± 0.04 µM), chrysoeriol (3, 0.62 ± 0.03 µM), and apigenin (2, 0.76 ± 0.07 µM). Allopurinol, used as the positive control, exhibited an IC50 of 4.2 ± 0.4 µM. Kinetic analysis indicated mixed-type inhibition, with KI and KIS values of 0.079 and 0.158 µM, respectively. Molecular docking suggested differences in predicted interactions between two hypothetical stereochemical models, although the absolute configuration of the isolated compound was not determined. Conclusions: Affinity-guided dereplication identified potent XO-inhibitory constituents of H. anthelmintica, highlighting hydnocarpin as the strongest inhibitor among those tested and supporting further mechanistic investigation.

PharmaceuticalsVol. 19(11)
Korea Institute of Oriental Medicine (KR), Korea University of Science and Technology (KR)
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon